Analysts’ Price Target Changes for September 3rd (CASY, CIEN, CXM, FIVE, NTSK, PAA, PAGP, PVH, RARE, SNOW)

Analysts’ price target changes for Thursday, September 3rd:

Casey’s General Stores (NASDAQ:CASY) had its target price trimmed by JPMorgan Chase & Co. from $975.00 to $833.00. They currently have a neutral rating on the stock.

Ciena (NYSE:CIEN) had its target price lowered by Needham & Company LLC from $600.00 to $520.00. Needham & Company LLC currently has a buy rating on the stock.

Sprinklr (NYSE:CXM) had its target price boosted by DA Davidson from $6.00 to $6.50. DA Davidson currently has a neutral rating on the stock.

Five Below (NASDAQ:FIVE) had its target price increased by JPMorgan Chase & Co. from $325.00 to $368.00. The firm currently has an overweight rating on the stock.

Netskope (NASDAQ:NTSK) had its target price increased by JPMorgan Chase & Co. from $16.00 to $18.00. The firm currently has an overweight rating on the stock.

Plains All American Pipeline (NASDAQ:PAA) had its target price increased by JPMorgan Chase & Co. from $24.00 to $27.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Plains GP (NYSE:PAGP) had its price target boosted by JPMorgan Chase & Co. from $24.00 to $27.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

PVH (NYSE:PVH) had its target price reduced by JPMorgan Chase & Co. from $84.00 to $83.00. They currently have an underweight rating on the stock.

Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target reduced by Jefferies Financial Group Inc. from $77.00 to $28.00. Jefferies Financial Group Inc. currently has a buy rating on the stock.

Snowflake (NYSE:SNOW) had its target price increased by JPMorgan Chase & Co. from $285.00 to $426.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Weyerhaeuser (NYSE:WY) had its target price cut by JPMorgan Chase & Co. from $31.00 to $28.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Xencor (NASDAQ:XNCR) had its price target increased by JPMorgan Chase & Co. from $14.00 to $21.00. They currently have a neutral rating on the stock.

Zymeworks (NASDAQ:ZYME) had its target price increased by JPMorgan Chase & Co. from $31.00 to $33.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Receive News & Ratings for Casey's General Stores Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Casey's General Stores Inc and related companies with MarketBeat.com's FREE daily email newsletter.